Effects of Dapagliflozin Compared with Sitagliptin and Metformin in Drug-Naïve Japanese Patients with Type 2 Diabetes: A 12-Week, Open-Label, Randomized, Active-Controlled Trial
Sign Up to like & getrecommendations! Published in 2021 at "Diabetes Therapy"
DOI: 10.1007/s13300-021-01176-x
Abstract: To compare the efficacy and tolerability of dapagliflozin with those of sitagliptin and metformin in patients with type 2 diabetes who have never received glucose-lowering agents. In this randomized, 12-week, open-label, active-controlled trial, 32 patients… read more here.
Keywords: patients type; week; sitagliptin metformin; type diabetes ... See more keywords
Pharmacoeconomic Analysis of Sitagliptin/Metformin for the Treatment of Type 2 Diabetes Mellitus: A Cost-Effectiveness Study.
Sign Up to like & getrecommendations! Published in 2021 at "Value in health regional issues"
DOI: 10.1016/j.vhri.2020.11.008
Abstract: OBJECTIVES To assess the cost-effectiveness and cost utility of sitagliptin/metformin for the treatment of type 2 diabetes mellitus compared to those of glibenclamide/metformin in a semiprivate hospital and to compare the cost-effectiveness and cost utility… read more here.
Keywords: cost effectiveness; cost; sitagliptin metformin;